Literature DB >> 14980036

Comparison of recovery time after open and laparoscopic gastric bypass and laparoscopic adjustable banding.

Barry L Fisher1.   

Abstract

BACKGROUND: Laparoscopy is believed to reduce recovery time and patient discomfort following bariatric surgical operations. This study tests that hypothesis.
METHODS: 60 randomly selected bariatric surgery patients, consisting of 20 open Roux-en-Y gastric bypass (RYGBP), 19 lap RYGBP, and 21 laparoscopic adjustable banding, were studied. Outcome measures including hospital length of stay (LOS), days to return to normal activity, days to surgical recovery, and pain medication usage were defined by the patients' subjective responses to a retrospective questionnaire. Overall differences among the three surgeries were first determined using the Kruskal-Wallis test, and then individual comparisons were made between each of the three pairs of operations using a Wilcoxon rank-sum test when a significant difference existed.
RESULTS: Patients reported an average LOS of 3.45 days following open RYGBP, 2.47 days following lap RYGBP, and 1.33 days following Lap-Band surgery. There was little difference in return to normal activity, with open RYGBP patients reporting a 17.55 day delay in return to normal activity, and lap RYGBP reporting an 18.16 day delay. In contrast, Lap-Band patients responded that the delay was only 7.24 days. Days to recovery were reported to be 29.05 for open RYGBP patients, 21.68 for lap RYGBP patients and 15.81 for Lap-Band patients. Hospital days (P=0.0002), days to normal activity (P=0.0115), and days to recovery (P<0.0001) differed significantly among the surgery types. Lap and open RYGBP did not differ significantly regarding days to resumption of normal activities. Open RYGBP and banding differed significantly regarding days to recovery (P <0.001).
CONCLUSIONS: Lap-Band patients returned to normal activity levels earlier than gastric bypass patient's irrespective of approach. Lap-Band patients also reported recovering from surgery significantly sooner than open RYGBP patients. Perceived differences in recovery time between open and laparoscopic RYGBP patients did not affect their time to resumption of normal activity.

Entities:  

Mesh:

Year:  2004        PMID: 14980036     DOI: 10.1381/096089204772787310

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  7 in total

Review 1.  Bariatric surgery: cost-effectiveness and budget impact.

Authors:  Lorenzo Terranova; Luca Busetto; Annarita Vestri; Marco Antonio Zappa
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

Review 2.  Surgery for morbid obesity.

Authors:  John M H Bennett; Samir Mehta; Michael Rhodes
Journal:  Postgrad Med J       Date:  2007-01       Impact factor: 2.401

3.  A comparison of 399 open and 568 laparoscopic gastric bypasses performed during a 4-year period.

Authors:  N Sekhar; A Torquati; Y Youssef; J K Wright; W O Richards
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

Review 4.  Randomized controlled trials in bariatric surgery.

Authors:  Chien-Pin Chan; Bing-Yen Wang; Ching-Yuan Cheng; Ching-Hsiung Lin; Ming-Chia Hsieh; Jun-Jiun Tsou; Wei-Jei Lee
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

5.  Comparison of the benefits and complications between laparoscopic and open Roux-en-Y gastric bypass surgeries.

Authors:  R T Marema; M Perez; C K Buffington
Journal:  Surg Endosc       Date:  2005-02-03       Impact factor: 4.584

Review 6.  Current Status of Bariatric and Metabolic Surgery in Korea.

Authors:  Youn Baik Choi
Journal:  Endocrinol Metab (Seoul)       Date:  2016-11-04

7.  Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgery.

Authors:  Yeyoung Han; Gihyeon Kim; Eunyong Ahn; Sunhee Jung; Youngae Jung; Yunjae Kim; Eunyoung Ha; Yoonseok Heo; Do Hyun Ryu; Hansoo Park; Geum-Sook Hwang
Journal:  Diabetes Obes Metab       Date:  2022-03-24       Impact factor: 6.408

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.